141 related articles for article (PubMed ID: 31290351)
1. Modulation of selenium-dependent glutathione peroxidase activity enhances doxorubicin-induced apoptosis, tumour cell killing and hydroxyl radical production in human NCI/ADR-RES cancer cells despite high-level P-glycoprotein expression.
Doroshow JH; Juhasz A
Free Radic Res; 2019 Aug; 53(8):882-891. PubMed ID: 31290351
[TBL] [Abstract][Full Text] [Related]
2. Control of doxorubicin-induced, reactive oxygen-related apoptosis by glutathione peroxidase 1 in cardiac fibroblasts.
Doroshow JH; Esworthy RS; Chu FF
Biochem Biophys Rep; 2020 Mar; 21():100709. PubMed ID: 31799454
[TBL] [Abstract][Full Text] [Related]
3. Enhanced glutathione peroxidase expression protects cells from hydroperoxides but not from radiation or doxorubicin.
Liebmann J; Fisher J; Lipschultz C; Kuno R; Kaufman DC
Cancer Res; 1995 Oct; 55(19):4465-70. PubMed ID: 7671261
[TBL] [Abstract][Full Text] [Related]
4. Modulation of glutathione peroxidase expression by selenium: effect on human MCF-7 breast cancer cell transfectants expressing a cellular glutathione peroxidase cDNA and doxorubicin-resistant MCF-7 cells.
Chu FF; Esworthy RS; Akman S; Doroshow JH
Nucleic Acids Res; 1990 Mar; 18(6):1531-9. PubMed ID: 2158080
[TBL] [Abstract][Full Text] [Related]
5. Contribution of glutathione and glutathione-dependent enzymes in the reversal of adriamycin resistance in colon carcinoma cell lines.
Lai GM; Moscow JA; Alvarez MG; Fojo AT; Bates SE
Int J Cancer; 1991 Nov; 49(5):688-95. PubMed ID: 1682279
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of catalase gene expression in the doxorubicin-resistant AML subline AML-2/DX100.
Kim HS; Lee TB; Choi CH
Biochem Biophys Res Commun; 2001 Feb; 281(1):109-14. PubMed ID: 11178967
[TBL] [Abstract][Full Text] [Related]
7. Resistance to oxidants associated with elevated catalase activity in HL-60 leukemia cells that overexpress multidrug-resistance protein does not contribute to the resistance to daunorubicin manifested by these cells.
Lenehan PF; Gutiérrez PL; Wagner JL; Milak N; Fisher GR; Ross DD
Cancer Chemother Pharmacol; 1995; 35(5):377-86. PubMed ID: 7850918
[TBL] [Abstract][Full Text] [Related]
8. Glutathione peroxidase-1 overexpression prevents ceramide production and partially inhibits apoptosis in doxorubicin-treated human breast carcinoma cells.
Gouazé V; Mirault ME; Carpentier S; Salvayre R; Levade T; Andrieu-Abadie N
Mol Pharmacol; 2001 Sep; 60(3):488-96. PubMed ID: 11502879
[TBL] [Abstract][Full Text] [Related]
9. Intracellular Doppler Spectroscopy detects altered drug response in SKOV3 tumor spheroids with silenced or inhibited P-glycoprotein.
Narayanan G; Merrill D; An R; Nolte DD; Turek JJ
Biochem Biophys Res Commun; 2019 Jul; 514(4):1154-1159. PubMed ID: 31103263
[TBL] [Abstract][Full Text] [Related]
10. B cell translocation gene 2 enhances susceptibility of HeLa cells to doxorubicin-induced oxidative damage.
Lim YB; Park TJ; Lim IK
J Biol Chem; 2008 Nov; 283(48):33110-8. PubMed ID: 18840609
[TBL] [Abstract][Full Text] [Related]
11. Decreased mutation rate for cellular resistance to doxorubicin and suppression of mdr1 gene activation by the cyclosporin PSC 833.
Beketic-Oreskovic L; Durán GE; Chen KG; Dumontet C; Sikic BI
J Natl Cancer Inst; 1995 Nov; 87(21):1593-602. PubMed ID: 7563202
[TBL] [Abstract][Full Text] [Related]
12. Hyperexpression of catalase in selenium-deprived murine L1210 cells.
Lin F; Thomas JP; Girotti AW
Arch Biochem Biophys; 1993 Aug; 305(1):176-85. PubMed ID: 8342949
[TBL] [Abstract][Full Text] [Related]
13. Doxorubicin-resistant variants of human prostate cancer cell lines DU 145, PC-3, PPC-1, and TSU-PR1: characterization of biochemical determinants of antineoplastic drug sensitivity.
David-Beabes GL; Overman MJ; Petrofski JA; Campbell PA; de Marzo AM; Nelson WG
Int J Oncol; 2000 Dec; 17(6):1077-86. PubMed ID: 11078791
[TBL] [Abstract][Full Text] [Related]
14. Increased glutathione peroxidase activity in a human sarcoma cell line with inherent doxorubicin resistance.
Samuels BL; Murray JL; Cohen MB; Safa AR; Sinha BK; Townsend AJ; Beckett MA; Weichselbaum RR
Cancer Res; 1991 Jan; 51(2):521-7. PubMed ID: 1845955
[TBL] [Abstract][Full Text] [Related]
15. Reversal of multidrug resistance by transduction of cytokine genes into human colon carcinoma cells.
Stein U; Walther W; Shoemaker RH
J Natl Cancer Inst; 1996 Oct; 88(19):1383-92. PubMed ID: 8827016
[TBL] [Abstract][Full Text] [Related]
16. Reversal effects of nomegestrol acetate on multidrug resistance in adriamycin-resistant MCF7 breast cancer cell line.
Li J; Xu LZ; He KL; Guo WJ; Zheng YH; Xia P; Chen Y
Breast Cancer Res; 2001; 3(4):253-63. PubMed ID: 11434876
[TBL] [Abstract][Full Text] [Related]
17. Selenium regulation of glutathione peroxidase in human hepatoma cell line Hep3B.
Baker RD; Baker SS; LaRosa K; Whitney C; Newburger PE
Arch Biochem Biophys; 1993 Jul; 304(1):53-7. PubMed ID: 8391784
[TBL] [Abstract][Full Text] [Related]
18. Mitochondria-Targeted Doxorubicin: A New Therapeutic Strategy against Doxorubicin-Resistant Osteosarcoma.
Buondonno I; Gazzano E; Jean SR; Audrito V; Kopecka J; Fanelli M; Salaroglio IC; Costamagna C; Roato I; Mungo E; Hattinger CM; Deaglio S; Kelley SO; Serra M; Riganti C
Mol Cancer Ther; 2016 Nov; 15(11):2640-2652. PubMed ID: 27466354
[TBL] [Abstract][Full Text] [Related]
19. Glutathione S-transferase and glutathione peroxidase are essential in the early stage of adriamycin resistance before P-glycoprotein overexpression in HOB1 lymphoma cells.
Lee WP; Lee CL; Lin HC
Cancer Chemother Pharmacol; 1996; 38(1):45-51. PubMed ID: 8603451
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of Pgp activity and cell cycle-dependent chemosensitivity to doxorubicin in the multidrug-resistant LoVo human colon cancer cell line.
Toffoli G; Corona G; Gigante M; Boiocchi M
Eur J Cancer; 1996 Aug; 32A(9):1591-7. PubMed ID: 8911123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]